Sienna Biopharmaceuticals, Inc. Restructuring Costs
Sienna Biopharmaceuticals, Inc. reported Restructuring Costs of $1.10 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2019-11-12
- Sienna Biopharmaceuticals, Inc. restructuring costs for the quarter ending 2019-09-30 was $1.10M.
| Period end | Restructuring Costs 3 month |
|---|---|
| 2019-09-30 | $1.10M 10-Q · filed 2019-11-12 |